Forecast
There is no analyst data available for this company.
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
Meiji Holdings: operating profit exceeds plan despite rising raw material costs
Meiji Holdings reported a consolidated operating profit of ¥40.9 billion for H1 FY2025, 3.7% above its internal plan despite a 7.8% year‑on‑year decline. Net sales edged up to ¥574.8 billion but remained 2.4% below plan, while profit attributable to owners fell to ¥21.4 billion. Meiji carried out price increases and structural reforms, highlighted strong pharmaceutical performance, and confirmed its full‑year operating profit target of ¥91.0 billion, but cut its sales forecast to ¥1,177.0 billion. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsIn 2026, Meiji has already paid €0.28 in dividends. The last payout was in June.
Financials
In the last quarter, Meiji had revenue of €1.73bn and net profit of €77.17m
| (EUR) | September 2026 | YoY |
|---|---|---|
| Revenue | 1.73bn | 0.21% |
| Gross profit | 530.41m | 2.88% |
| Net profit | 77.17m | 17.76% |
| EBITDA | 228.57m | 14.96% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €7.2bn |
Number of shares | 271.18m |
52-week high/low | €27.24 - €18.09 |
Dividend yield | 2.22% |
Dividends TTM | €0.57 |
Next dividend | €0.32 |
Beta | 0.11 |
P/E ratio | 29.36 |
PEG ratio | -4.76 |
P/B ratio | 1.60 |
P/S ratio | 1.05 |
Company profile
Meiji Holdings Co., Ltd., through its subsidiaries, manufactures and sells dairy products, confectioneries, nutritional products, and pharmaceuticals in Japan and internationally. The company operates through two segments, Food and Pharmaceutical. It provides yogurt, drinking milk, beverages, cheese, butter and margarine, cream, ice cream, frozen foods, chocolates, gummy products, chewing gums, candies, sports nutrition products, infant and eternal formula, beauty supplements, OTC drugs, livestock products, and sugar, as well as transportation and distribution services. The company also provides drugs for infectious diseases and central nervous system disorders, as well as generic drugs; agricultural and livestock chemicals; human and veterinary vaccines, and blood plasma products; and veterinary drugs for livestock and fisheries comprising antimicrobial injection, oral administration, antipyretic, analgesic, anti-inflammatory, hemostatic, and breeding agents, disinfectants, insecticides, anthelmintics, metabolites, feed additives, and mixed feed; and companion animals, including anesthetics and painkillers, anti-parasitic and gastrointestinal drugs, anti-bacterial agents, antiplasmin agents, vitamin E preparations, and dietary supplements. Meiji Holdings Co., Ltd. was founded in 1916 and is headquartered in Tokyo, Japan.
| Name | Meiji |
| CEO | Katsunari Matsuda |
| Headquarters | Tokyo,
ty Japan |
| Website | |
| IPO | 04/01/2000 |
| Employees | 17,103 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Japan Exchange Group | 2269.T |
Pnk | MEJHF |
Frankfurt | 3M0.F |
Düsseldorf | 3M0.DU |
München | 3M0.MU |